/24-7PressRelease/ - PISCATAWAY, NJ, August 28, 2008 - International research outsourcing company GenScript Corporation announces its support and sponsorship of SB4.0, the fourth annual international convention dedicated to the field of synthetic biology. SB4.0 is to be held on October 10-12th, 2008 at Hong Kong's University of Science and Technology.
Synthetic biology is a new branch of bioengineering emphasizing technologies that involve the synthesis of important biological molecules, such as DNA. It has applications in bioenergy, drug production, medicine, and the development of new materials. There have been three successful international synthetic biology conferences in the past: SB1.0 at MIT, SB2.0 at UC Berkeley, and SB3.0 at ETH Zurich, respectively.
GenScript has been a leader in the field of synthetic biology for many years. Many of its products and services involve gene synthesis, peptide design and synthesis, protein expression and refolding, large-scale protein production, large-scale polyclonal and monoclonal antibody production, express polyclonal antibody production, affinity purification, conjugation, fragmentation, and immunoassay development. GenScript also offers early drug discovery services, mammalian cell line development, immunoassay development, and patch clamp hERG safety testing. Furthermore, GenScript¡¯s sensitive and efficient One-Step Western; Kits, One-Step IP-Western Kits, and specialized PCR reagents have gradually gained recognition and favor in both industry settings and in the academic world.
http://sb4.biobricks.org/
For further information, please contact:
Sally Wang, Director of Sales
GENSCRIPT CORPORATION
(877) 436-7274
sallyw@GenScript.com
One stop for gene, peptide, protein, and antibody services.
Copy Right 2007 GENSCRIPT CORP. All rights reserved. SPECIFIC PRODUCT MENTIONED is a registered trademark of GenScript Corp.
# # #
- 4.0, bioengineering, biology, blot, genscript, hong, kits., kong, one, step, synthetic, western
Read more Press Releases from Yunfan Li:Other Press Release Headlines:
